Peter Glick, Chairman of the Board
Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, and Blue Sky Bioservices. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.